ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China
· Delayed Price · Currency is CNY 39.82
+1.11 (2.87%)
Apr 29, 2026, 3:04 PM CST
SHE:300723 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 17,382 | 15,065 | 7,660 | 13,394 | 9,894 | 10,200 | Upgrade
|
| Market Cap Growth | 51.80% | 96.66% | -42.81% | 35.38% | -3.00% | 60.89% | Upgrade
|
| Enterprise Value | 18,100 | 16,527 | 8,774 | 13,988 | 10,650 | 10,763 | Upgrade
|
| Last Close Price | 38.71 | 33.55 | 17.06 | 29.55 | 22.74 | 23.45 | Upgrade
|
| PE Ratio | 87.44 | - | - | 72.55 | 34.04 | 33.23 | Upgrade
|
| Forward PE | - | 72.94 | 30.13 | 30.71 | 19.18 | 33.61 | Upgrade
|
| PS Ratio | 18.48 | 16.16 | 5.28 | 5.35 | 4.34 | 4.64 | Upgrade
|
| PB Ratio | 8.82 | 10.71 | 3.96 | 5.16 | 4.57 | 5.05 | Upgrade
|
| P/TBV Ratio | 11.13 | 15.39 | 5.28 | 6.49 | 6.27 | 7.27 | Upgrade
|
| P/FCF Ratio | - | - | - | 108.38 | - | - | Upgrade
|
| P/OCF Ratio | 658.84 | 327.41 | - | 29.24 | 20.81 | 23.28 | Upgrade
|
| EV/Sales Ratio | 19.24 | 17.73 | 6.05 | 5.59 | 4.67 | 4.89 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 36.11 | 29.06 | 35.20 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 60.99 | 36.15 | 42.00 | Upgrade
|
| EV/FCF Ratio | -211.91 | - | - | 113.18 | - | - | Upgrade
|
| Debt / Equity Ratio | 1.06 | 1.47 | 0.87 | 0.31 | 0.54 | 0.61 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 1.95 | 2.98 | 3.73 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 6.49 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.35 | 1.11 | 0.63 | 0.13 | 0.21 | 0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | -27.94 | -29.09 | -10.54 | 0.87 | 1.23 | 0.46 | Upgrade
|
| Net Debt / FCF Ratio | -7.99 | -19.18 | -1.40 | 2.74 | -3.45 | -1.13 | Upgrade
|
| Asset Turnover | 0.19 | 0.22 | 0.33 | 0.59 | 0.58 | 0.75 | Upgrade
|
| Inventory Turnover | 1.59 | 1.61 | 1.82 | 1.84 | 2.05 | 2.86 | Upgrade
|
| Quick Ratio | 1.22 | 0.70 | 0.48 | 0.62 | 0.93 | 1.13 | Upgrade
|
| Current Ratio | 1.45 | 0.97 | 0.73 | 0.91 | 1.17 | 1.30 | Upgrade
|
| Return on Equity (ROE) | 9.73% | -20.73% | -25.00% | 6.37% | 12.53% | 16.70% | Upgrade
|
| Return on Assets (ROA) | -2.84% | -3.70% | -4.16% | 3.37% | 4.71% | 5.45% | Upgrade
|
| Return on Invested Capital (ROIC) | -8.04% | -8.18% | -9.64% | 5.14% | 9.91% | 12.94% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.90% | -8.60% | -11.00% | 7.90% | 10.20% | 10.20% | Upgrade
|
| Earnings Yield | 1.15% | -2.24% | -7.05% | 1.38% | 2.94% | 3.01% | Upgrade
|
| FCF Yield | -0.49% | -0.54% | -11.36% | 0.92% | -1.32% | -1.21% | Upgrade
|
| Dividend Yield | - | - | - | 0.71% | 0.59% | 0.57% | Upgrade
|
| Payout Ratio | 30.85% | - | - | 35.77% | 21.88% | 12.90% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | -0.01% | 0.00% | -4.43% | -1.94% | 2.20% | Upgrade
|
| Total Shareholder Return | -0.02% | -0.01% | 0.00% | -3.72% | -1.35% | 2.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.